血小板衍生生长因子C(PDGF-C)介导肾纤维化与高血压
在Alport小鼠(Col4A3-/-)模型中,PDGF-C缺失或中和抗体可降低血肌酐和尿素氮、减轻肾小球损伤、纤维化及炎症;意外发现中和PDGF-C抗体还降低收缩压,并改善血管功能;机制涉及PDGF-C上调血管紧张素原及AT1受体表达。
要点
- PDGF-C缺失或中和可减轻Alport小鼠肾脏损伤、纤维化和炎症。
- 中和PDGF-C抗体降低Alport和野生型小鼠收缩压并改善血管张力。
- PDGF-C通过上调血管紧张素原和AT1受体参与高血压发生。
核心结论
- PDGF-C不仅介导肾纤维化,还通过影响肾血管和肾素-血管紧张素系统介导高血压。
研究设计与样本
- 研究在Col4A3-/-(Alport)小鼠中进行,采用PDGF-C基因敲除或中和PDGF-C抗体干预,并包含野生型小鼠及体外实验。
主要发现
- PDGF-C缺失和中和均降低Alport小鼠血清肌酐和血尿素氮水平,减轻肾小球损伤、肾纤维化和肾脏炎症。
- 中和PDGF-C抗体降低Alport和野生型小鼠收缩压,并减少Alport小鼠肾皮质动脉壁厚度。
- 抗PDGF-C处理的野生型小鼠主动脉环张力降低、舒张加快。
- 体外PDGF-C上调主动脉组织和原代肝细胞中血管紧张素原,并诱导肝细胞中NFκB/p65结合血管紧张素原启动子。
- 中和PDGF-C抑制Alport小鼠血管紧张素原转录表达以及Alport和野生型小鼠AT1受体表达;中和PDGF-C抗体改善血管紧张素II诱导的健康小鼠高血压。
临床怎么用
- PDGF-C同时参与肾纤维化和高血压,是进展性肾病有吸引力的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Platelet-derived growth factors (PDGF) have been implicated in kidney disease progression. We previously found that PDGF-C is upregulated at sites of renal fibrosis and that antagonism of PDGF-C reduces fibrosis in the unilateral ureteral obstruction model. We studied the role of PDGF-C in collagen 4A3-/- ("Alport") mice, a model of progressive renal fibrosis with greater relevance to human kidney disease. Alport mice were crossbred with PDGF-C-/- mice or administered a neutralizing PDGF-C antibody. Both PDGF-C deficiency and neutralization reduced serum creatinine and blood urea nitrogen levels and mitigated glomerular injury, renal fibrosis, and renal inflammation. Unexpectedly, systolic blood pressure was also reduced in both Alport and wild-type mice treated with a neutralizing PDGF-C antibody. Neutralization of PDGF-C reduced arterial wall thickness in the renal cortex of Alport mice. Aortic rings isolated from anti-PDGF-C-treated wildtype mice exhibited reduced tension and faster relaxation than those of untreated mice. In vitro, PDGF-C upregulated angiotensinogen in aortic tissue and in primary hepatocytes and induced nuclear factor κB (NFκB)/p65-binding to the angiotensinogen promoter in hepatocytes. Neutralization of PDGF-C suppressed transcript expression of angiotensinogen in Alport mice and angiotensin II receptor type 1 in Alport and wildtype mice. Finally, administration of neutralizing PDGF-C antibodies ameliorated angiotensin II-induced hypertension in healthy mice. Thus, in addition to its key role in mediating renal fibrosis, we identified PDGF-C as a mediator of hypertension via effects on renal vasculature and on the renin-angiotensin system. The contribution to both renal fibrosis and hypertension render PDGF-C an attractive target in progressive kidney disease.
引用
- van Roeyen CRC, Martin IV, Drescher A, et al. Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension. Kidney Int. 2019. PMID: 30827511. doi:10.1016/j.kint.2018.11.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。